40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Analyze DCF forecasts for the company and compare them with competitors.
6.73B
No previous data to compare.
No Data
No DCF data available for this metric in the selected year.
2.75B
No previous data to compare.
40.87%
No previous data to compare.
697.00M
No previous data to compare.
10.36%
No previous data to compare.
2.05B
No previous data to compare.
190.00M
No previous data to compare.
2.82%
No previous data to compare.
1.15B
No previous data to compare.
17.04%
No previous data to compare.
7.00M
No previous data to compare.
0.10%
No previous data to compare.
348.00M
No previous data to compare.
5.17%
No previous data to compare.
-2.63B
No previous data to compare.
-39.04%
No previous data to compare.
11.70%
No previous data to compare.
16.87%
No previous data to compare.
5.31%
No previous data to compare.
2.64
No previous data to compare.
263.90M
No previous data to compare.
6.68B
No previous data to compare.
10.03B
No previous data to compare.
16.71B
No previous data to compare.
39.98%
No previous data to compare.
60.02%
No previous data to compare.
517.77M
No previous data to compare.
-861.23M
No previous data to compare.
0.50%
No previous data to compare.
-12.22B
No previous data to compare.
-11.02B
No previous data to compare.
6.68B
No previous data to compare.
-17.70B
No previous data to compare.
-67.06
No previous data to compare.
Analyze analyst forecasts for the company and compare them with competitors.
6.13B
The estimated revenue has decreased from the previous period.
-6.18B
The estimated EBITDA has decreased from the previous period.
0.19
The estimated EPS has decreased from the previous period.
-7.05B
The estimated net income has decreased from the previous period.
-6.20B
The estimated EBIT has decreased from the previous period.
447.24M
The estimated SG&A expenses have increased from the previous period.
View analysts' price targets and recommendations, and compare them with competitors.
$52.00
Lower upside than AR's upside of 54.83%.
Buy
Equal to AR's analyst recommendation of Buy.
